In this post, our Roundup lawyers will give you:
- An update on where things stand in the new $7.5 billion Roundup class action lawsuit settlement in June 2026
- The likely direction the Roundup litigation will take moving forward, and
In this post, our Roundup lawyers will give you:
Our lawyers are actively reviewing hair relaxer cancer lawsuits across all 50 states. This page provides:
Our lawyers are investigating gambling addiction lawsuits involving DraftKings, FanDuel, BetMGM, Caesars, ESPN Bet, Bet365, Fanatics Sportsbook, Hard Rock Bet, and other online betting platforms. The core allegation is that these companies had the data to see compulsive gambling behavior and, instead of slowing users down, kept pushing them with bonus bets, deposit matches, push notifications, VIP hosts, profit boosts, same game parlays, microbets, and personalized offers.
If you or your child suffered serious harm from online sports betting addiction, the first question is not whether gambling was legal. The first question is whether the platform used design, data, and marketing to keep a vulnerable user betting when a responsible operator should have stepped in.
If you or someone you love has suffered severe financial and emotional harm because of addiction to online gambling or sports betting, contact our lawyers at 800-553-8082 or get a free, no-obligation online consultation.
Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas. Our law firm is reviewing NEC lawsuits in all 50 states.
Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis. These newborn NEC formula lawsuits make many allegations. But at their core, they allege that the makers of these formulas knew of the risk of NEC and did nothing to warn families and give them a choice.
If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to participate in a class action lawsuit against the formula companies and receive financial compensation for the harm that was done to your child.
Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading
This page is about social media addiction lawsuits and who is eligible to bring a claim. Our lawyers also provide the latest news on social media class action lawsuits (including the ongoing trial in California).
The problem that led to social media lawsuits is that millions of people, too many of whom are children, are addicted to social media platforms such as Facebook, Instagram, Snapchat, and others. For these vulnerable users, social media addiction can be very harmful and lead to things like eating disorders, depression, and, in some cases, suicide.
Now, these companies are facing a wave of new social media lawsuits alleging that they knowingly designed the algorithms of their platforms to lure young people into harmful addictions.
These cases are still developing, and we are in the early rounds of this. There is no nationwide gabapentin dementia MDL, no approved class action settlement, and no guaranteed payout. But the science is advancing, and the legal theories are strengthening as the evidence grows.
Gabapentin is one of the most commonly prescribed medications in the United States. It is sold under the brand name Neurontin and is also available as a generic. Doctors prescribe Neurontin for seizures, shingles-related nerve pain, and a long list of off-label conditions, including back pain, neuropathy, anxiety, migraines, fibromyalgia, sleep problems, and other chronic pain complaints.
For sickle cell patients and families, Oxbryta was supposed to be a lifeline. Instead, it left many worse off–facing new health crises, hospitalizations, and in some cases, unthinkable loss. Now, Oxbryta lawsuits are uncovering what Pfizer knew and when it knew it.
Oxbryta is a prescription drug developed by Global Blood Therapeutics and later acquired by Pfizer. It was voluntarily recalled in September 2024 after new evidence revealed that it caused serious and potentially fatal complications, including vaso-occlusive crises and organ damage.
This page looks at Oxbryta lawsuits and their potential settlement value.
Oxbryta is a prescription drug made by Pfizer that was recalled in September 2024 after evidence revealed that it caused a number of very serious and potentially fatal health problems, including vaso-occlusive crisis and organ damage. Continue reading
We have also recently reopened the comments below to answer any questions you may have or simply give you a chance to share your thoughts.